The prevalence and the severity of erectile dysfunction (ED) increase with advancing age; different pathogenetic factors could contribute to age-related ED. We studied organic, relational and intrapsychic components of ED as a function of patients' age in a consecutive series of 977 patients with ED, using the specifically designed structured interview SIEDY r . A complete physical examination and a series of biochemical, hormonal, psychometric and penile vascular tests were also performed. Relational factors seems to be more relevant in patients aged over 60 y, while intrapsychic disturbances play a major role in younger subjects. Organic factors are the most important determinant of ED in all age groups, but their contribution is more important in older patients. In fact, basal and dynamic peak cavernosal velocity at Doppler ultrasound penile examination was reduced in older patients. Among hormonal factors, the body mass indexdependent reduction of testosterone in older patients does not seem to play a crucial role in the pathogenesis of ED. No significant correlation was observed between testosterone level and the severity of ED, although patients reporting hypoactive sexual desire showed significantly lower testosterone levels when compared with the rest of the sample. A better understanding of the relative contribution of age-related pathogenetic factors of ED could be of help in the design of appropriate therapeutic approaches.
Introduction
The prevalence and the severity of erectile dysfunction (ED) increases with advancing age. [1] [2] [3] [4] [5] [6] [7] [8] In the Massachusetts Male Aging Study, 3 the proportion of subjects with severe ED increased from 5% at the age of 40 y to 15% at the age of 70 y.
Many different factors could contribute to agerelated ED. 2, 3, 5 Elderly patients are often affected by multiple organic diseases, which can interfere with sexual function. In particular, cardiovascular and metabolic diseases with increased prevalence in the elderly (including coronary artery disease, myocardial infarction, hypertension, hyperlipidemia, diabetes mellitus and peripheral vascular disease) could play a crucial role in the pathogenesis of many cases of age-related sexual dysfunction.
3,5,9-11 Considering its frequent association with cardiovascular diseases and cardiovascular risk factors, ED has been proposed as a possible marker of occult ischemic heart diseases. 3, 5, 11, 12 Age-related modifications in endocrine function could also contribute to the increased prevalence of ED in the elderly. Testosterone levels are known to decline with aging. [13] [14] [15] Although this phenomenon is correlated with age-dependent decrease of libido, its contribution to ED does not seem to be crucial. 16, 17 Furthermore, many chronic degenerative neurological disease such Parkinson's and Alzheimer's disease could contribute to the increase of ED with age. 2 Among psychological factors, the association of aging and depression is controversial. The prevalence of depressive disorders increases progressively with age until the age of about 60 y, remains stable in the following 15-20 y, and increases again in the very old. 18, 19 A wide body of evidence supports the hypothesis of a strong association between depression and ED. 2, 3, 5 Depressive symptoms could therefore contribute to the increased prevalence of ED.
The use of psychotropic drugs such as antidepressants and antipsychotic represents an independent age-related factor contributing to ED. 1, 20 Furthermore, the use of many other medications such as antihypertensive, cardiovascular, and prokinetic drugs has been associated with ED. 21, 22 The age-dependent increase in the use of these medications may play an important role in the determination of ED in older patients. [21] [22] [23] Another factor which could theoretically contribute to the increased prevalence of ED in the elderly is the loss of interest in the partner or the decrease in partner's sexual interest. 24 Very few studies 8, [24] [25] [26] analyzed the contribution of marriage and relational factors to ED in patients, and none of them investigated their age course. Hypoactive sexual desire (HSD), which can be related to psychological and/or endocrine factors, is a relevant determinant of reduced sexual activity at all ages. We recently observed that sexual desire does not decline in the aging male, while it steeply declines with aging in patients' partners, suggesting a possible increased involvement of relational factors in elderly patients. 27 The aim of this study is to determine the contribution of organic, relational, and intrapsychic components to the pathogenesis of ED as a function of patients' age, using a validated interview which explores these three domains. 26 This is a 13-item structured interview, with three factor analysisderived scales, which measure the organic, relational and intrapsychic components of ED. These three factors are often simultaneously present in ED patient and mutually contribute to the pathogenesis of ED. Previously described instruments for the assessment of the pathogenesis of ED are either very long or insufficiently validated, or both. 28 It is noteworthy that, in contrast with previously described instruments, scales of SIEDY were identified through factor analysis, and not predetermined by the authors; this procedure allowed the identification of a scale measuring relational disturbances, which were not assessed by previously described instruments. 26 
Patients and methods
A consecutive series of 977 patients, aged 52.5712.4 y, attending for the first time the Outpatient Clinic for sexual dysfunction was studied. Patients with mental retardation, or coming from foreign countries, were excluded. Characteristics of the sample are summarized in Tables 1 and 2 . All patients enrolled were of Caucasian ethnicity.
The site at which the study was performed is a University Outpatient Clinic specifically devoted to the diagnosis and treatment of male sexual Patients were interviewed prior to the beginning of any treatment, and before any specific diagnostic procedures, using the SIEDY r structured interview. 26 This brief, multidimensional instrument designed for the pathogenetic assessment of ED provides scores for organic, marital and psychopathological factors affecting sexual function, which can be simultaneously present in the same patient.
Patients were asked to specify any current pharmacological treatment; drugs listed in Broderick and Foremann 21 were considered capable of interfering with sexual function.
Patients were asked to complete the Middlesex Hospital Questionnaire, modified (MHQ), 29 a brief self-reported questionnaire for the screening of mental disorders, which provides scores for freefloating anxiety, phobic anxiety, obsessive-compulsive traits and symptoms, hysterical traits and symptoms, somatization and depressive symptoms.
All patients underwent a complete physical examination with measurement of blood pressure (mean of three measurements 5 min apart, in sitting position, with a standard sphygmomanometer), height, weight and testis volume (Prader orchidometer). Blood samples were drawn in the morning, after overnight fast, for determination of blood glucose (by glucose oxidase method, Aeroset Abbott, Rome, Italy) total and HDL cholesterol and triglyceride (by automated enzymatic colorimetric method; Aeroset Abbott, Rome, Italy), testosterone, prolactin, FSH, LH, TSH and PSA (by electrochemiluminescent method, Modular Roche, Milan, Italy). All patients underwent a provocative test with intracavernosal PGE 1 (10 mg) as previously described. 30 In addition, because a normal PGE 1 responsiveness might be present also in patients with arteriogenic ED, 31, 32 penile duplex ultrasound examination was performed before and after PGE 1 intracavernous injection (10 mg) in all patients. The following parameters were considered: basal peak systolic velocity and acceleration, peak systolic velocity, and end diastolic velocity after PGE 1 intracavernous injection (10 mg), resistance index. 33 Nocturnal penile tumescence and rigidity were evaluated with a commercially available home monitor (Rigiscant, Dacomed Corp., Minneapolis, MN, USA) in a consecutive series of 130 patients, assessing tip rigidity and tumescence activity units (RAU and TAU, respectively) as previously described. 34 The demographic and clinical characteristics of those who underwent Rigiscant, examination (age, body mass index (BMI), glycemia, lipid profile, prevalence of hypertension, diabetes, endocrine disorders, and cardiovascular disease) were not significantly different from those of the rest of the sample (data not shown).
Data were expressed as mean7s.d. when normally distributed, and as median [quartiles] for parameters with non-normal distribution, unless otherwise specified. Differences among more than two groups were assessed with one-way ANOVA or Kruskal-Wallis test, whenever appropriate. Unpaired two-sided Student's t-tests were used for comparison of means of normally distributed parameters; when distribution could be normalized through logarithmic transformation, as in the case of prolactin, the same test was applied to logarithmically transformed data. In all other cases, MannWhitney U-test was used for comparisons between groups. Correlations were assessed using Spearman's or Pearson's method whenever appropriate. Stepwise multiple linear regression was applied for multivariate analysis, categorizing yes/no parameters as dummy 0/1 variables, whenever appropriate.
Severity of ED was categorized on a 4-point scale using question 1C of SIEDY r appendix A (erection not sufficient hard enough for penetration from: 0 ¼ o25, 1 ¼ 25-49, 2 ¼ 50-74, 3 ¼ Z75% of cases), as previously described. 26 The relative contribution of different pathogenetic factors to ED was assessed through a stepwise multiple linear regression, using SIEDY r scale scores as factors and ED severity as dependent variable. w 2 test was used for comparison of categorical parameters.
All statistical analysis was performed on SPSS for Windows 10.0. 
Results

Aging and clinical features of sexual dysfunction
Among the patients referring to the Outpatient Clinic for sexual dysfunction, the proportion of those affected by ED increased significantly (Po0.01 at ANOVA) with age; in particular, the prevalence of severe ED (erection absent or insufficient for intercourse in over 75% of occasions) was significantly (Po0.01 at ANOVA) higher in older patients (Figure 1 ). The increase of prevalence of severe ED was most clearly evident from the age of 60 y, that is from the seventh decade onwards. A similar pattern was observed with the analysis of rigidometric parameters (Figure 1, insets 27 The proportion of patients reporting HSD was 37.2% among those under 60 y, 37.3% between 60 and 70 y, and 32.3% over 70 y old. No significant association was found between patient's libido and age of partner, while an agedependent reduction of sexual desire, as reported by the patients, was observed in the patients' partners. In particular, HSD in partners was reported by 31.6% of the patients when age of partner was over 60 y, vs 15.8% in the rest of the sample (Po0.001).
Aging and pathogenetic factors of sexual dysfunction: endocrine factors
Hormonal levels in different age groups are summarized in Table 1 . Testosterone levels showed a significant inverse correlation with age (r ¼ À0.123; Po0.001). Follicile-stimulating hormone (FSH) and leutinizing harmone (LH) were directly correlated with age (r ¼ 0.363 and 0.188 respectively; both Po0.001). Patients in the higher age groups showed lower testosterone and higher gonadotropins levels (Po0.01 among groups at ANOVA). The proportion of hypogonadal patients (testosteroneo10 nmol/l) was significantly higher among those aged over 50 y than in the rest of the sample (14.1 vs 7.6%; Po0.01), while the proportion of severe hyperprolactinemic (prolactin4700 mU/l), hypothyroid (TSH410 mU/l), and hyperthyroid (TSHo0.01 -mU/l) patients was not significantly different in the various age groups (data not shown).
A significant (Po0.001) inverse correlation (r ¼ À0.271) of testosterone levels was also observed with BMI; BMI, in turn, was directly correlated with age (r ¼ 0.236; Po0.001). When applying a multiple regression analysis, testosterone levels showed a significant correlation with BMI (adj. R ¼ À0.27; Po0.01), but not with age.
Testosterone levels in patients with severe ED were not significantly different from those of the rest of the sample (16.276.3 vs 16.175.9 nmol/l; P ¼ NS). Patients with different frequency of sexual intercourses (investigating using a 0-3 Likert scale from ¼ 0 nonsexual intercourses to 3 ¼ over eight attempts/month) did not show any significant difference in testosterone levels (data not shown). On the other hand, patients reporting HSD showed significantly lower testosterone levels when compared with the rest of the sample (15.375.6 vs 16.676.1 nmol/l, respectively; Po0.005); the difference remained significant at multivariate analysis after adjustment for age (Po0.005).
Aging and pathogenetic factors of sexual dysfunction: cardiovascular disease and other somatic factors
A greater proportion of patients reported current or previous cardiovascular disease (coronary artery disease, stroke, arteriopathy of lower limbs, or any other known arterial disease) with advancing age (Figure 2 ). The prevalence of reported cardiovascular disease was 1.9, 0.8, 4.7, 9.6, 19.2 and 33.3% in patients aged o30, 30-39, 40-49, 50-59, 60-69 and Z70 y old, respectively (Po0.01 among groups). A significant (Po0.001 at Kruskal-Wallis) increase of the prevalence of diabetes and hypertension, and a Figure 1 Prevalence of severe ED (erection insufficient for penetration in over 75% of cases) in different age groups. Insets: penile tip rigidity activity units (tip-RAU, inset A) and penile tip tumescence activity units (tip-TAU, inset B) expressed as mean and 95% confidence interval in different age groups (*Po0.05 vs patients under 40 y).
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significantly more frequent use of drugs potentially interfering with erectile function, was also observed in the highest age groups (Figure 2) . A significant increase of glycemia, triglyceride and total cholesterol was also observed in aging patients (Table 1 ; Po0.01 among groups at ANOVA). Figure 3 shows mean basal and PGE1-stimulated cavernosal peak systolic velocity in different age groups. Differences between groups were statistically significant at ANOVA (Po0.01). No significant difference was observed between patients under 30 y and those between 30 and 39 y old; a significant (Po0.0001) reduction of both parameters in comparison with patients under 40 y was already observed in the fifth decade, while no further decrease was detectable in the subsequent age ranges. Conversely, no significant variation of end diastolic velocity was observed in different age groups (data not shown).
Aging and pathogenetic factors of sexual dysfunction: psychological factors MHQ scores measuring free-floating anxiety (MHQ-A) showed a significant increase after the age of 30 y, without any further increase in the higher age groups; after the age of 70 y, MHQ-A scores were not significantly different from those of the youngest age group (Figure 4) . MHQ depressive symptoms score showed a significant increase with advancing age, which was evident from the fourth decade onwards (Figure 4) . A similar pattern was observed for phobic anxiety, obsessive-compulsive traits, and somatic symptoms (data not shown), while no variation of hysterical symptoms was observed with age.
MHQ scales measuring free-floating anxiety, somatic and depressive symptoms showed significant correlations with scale 3 of SIEDY, which measures the intrapsychic component of ED (r ¼ 0.35, 0.26 and 0.25, respectively; all Po0.0001). No significant correlation between SIEDY scale 3 and MHQ-scales measuring obsessive-compulsive traits, phobic anxiety and hysterical symptoms was observed.
Contribution of different pathogenetic factors to ED in different age groups
Scores of SIEDY r in patients of different age are summarized in Figure 5 . A significant increase in the scores of scale 1, exploring the organic component of ED, was observed after the age of 50 y. Scores of scale 2, assessing the relational components, showed a progressive increase from the fifth decade onwards. On the other hand, scores Aging and pathogenesis of ED G Corona et al of Scale 3, which explores the intrapsychic aspects of ED, increase significantly after the age of 30 y, without any further increase in the higher age groups; after the age of 60 y, scale 3 scores were not significantly different from those of the youngest age group.
A stepwise linear regression analysis, using reported severity of ED as dependent variable, and scores of the three scales of SIEDY r as putative factors, was performed in order to assess the relative contribution of each area to the pathogenesis of ED.
In particular, considering the reported erection quality and rigiscan parameters (in both cases a worse characteristic of erections after seventh decade; Figure 1 ) the age of 60 y was selected as cutoff for differentiating younger and older patients. In patients aged under 60 y, scale 1 and 3, but not scale 2, showed a significant (Po0.05) correlation with severity of ED, with adj. R of 0.30, 0.04 and 0.28 for scales 1, 2 and 3, respectively; in those patients, scales 1, 2 and 3 accounted for 9.0, 0.2 and 7.8% of variance of ED severity. Among those aged over 60 y, scale 1 and 2, but not scale 3, showed a significant (Po0.05) correlation with severity of ED (adj. R ¼ 0.52, 0.20 and 0.03 for scales 1, 2 and 3, respectively); scale 1, 2 and 3 explained 27.0, 4.0 and 0.1% of variance of ED severity. These results were confirmed when patients without a partner were excluded (data not shown).
Discussion
This study shows for the first time that not only organic, but also relational and intrapsychic domains contribute to the pathogenesis of ED in a different manner according to patients' age. The contribution of different domains to the pathogenesis of ED was assessed through the specifically designed SIEDY r interview. 26 It should be recognized that, although adequately validated, SIEDY is still a new instrument, and its use is not widespread.
While the relational disturbances increased with age, the intrapsychic ones showed a trend toward a decline in older patients. A similar pattern was observed in tests exploring depressive and freefloating anxiety symptoms. Accordingly, relational factors provide a significant contribution to the severity of ED in older patients only, while the reverse is true for intrapsychic factors; that is they contribute more to the severity of ED in the youngest.
It can be speculated that the increased impact of symptoms of anxiety and depression on ED in middle-aged individuals could be related to competition in the work environment, and to the effect of other stressors to which individuals are exposed during the more active periods of their life. On the other hand, the greater role of relational factors in older patients could be attributed, at least partly, to the age-related decrease of sexual desire of patients' partners. 24, 27 In fact, we observed that sexual desire is inversely related to age in patients' partners, but not in patients themselves, as previously reported; 27 for this reason, a discrepancy between male and female sexual desire, which could disturb relationship, can be observed in many aging couples. The increased impact of relational factors in aging individuals could partly explain the observed age- Aging and pathogenesis of ED G Corona et al related, comorbidity-independent, increase in the prevalence of ED, which was previously described. 35 These findings might suggest that a sexuological-psychotherapeutic approach to ED should be more focused on the relational disturbances in aged patients, and on intrapsychic aspects in younger subjects.
As expected, the organic component, as measured by SIEDY r , increases with age, and it accounts for a greater proportion of severity of ED in older patients. However, this component also explains a substantial fraction of variance of ED severity in younger patients.
The prevalence of known current or previous cardiovascular disease was significantly greater in the higher age groups, as expected; similarly, prevalence of hypertension and diabetes, and cholesterol and triglyceride levels, increased with age. The frequent comorbidity of multiple metabolic and hemodynamic abnormalities in the aging patients can increase substantially the incidence and progression of atherosclerotic lesions, leading to vascular forms of ED. These data suggest a greater impact of vascular lesions in the pathogenesis of ED in elderly patients, confirming previous reports. 3, 5, 9, 10, 11, 32 In fact, in our series, basal and dynamic peak systolic velocity at penile Doppler ultrasound examination are inversely correlated with age, as previously described. 5, 36 It is noteworthy that, in our sample, the reduction of Doppler parameters is evident from the age of 40 y onwards; a previous study on a small sample of patients showed an even earlier decline of dynamic peak systolic velocity with age, which was evident from the age of 30 y. 36 On the other hand, rigidometric abnormalities increase after the age of 60 y. The severity of ED, as perceived by patients, also increases after the age of 60 y. Hence, it could be speculated that penile Doppler ultrasound examination detects vascular dysfunction in a very early stage. 10 These results are in accordance with previous reports of normal rigidometric parameters in patients with reduced dynamic peak systolic velocity at Doppler examination. 37 It should also be observed that the use of drugs potentially interfering with sexual function 21 increases with advancing age with the increase of prevalence of comorbid condition. This phenomenon, together with the increased prevalence of metabolic and vascular abnormalities, suggests a greater contribution of organic components to the pathogenesis of ED in the elderly.
Testosterone levels showed a significant inverse correlation with age and BMI, confirming previous reports.
14,38 Furthermore, BMI was directly correlated with age in accordance with the age-related increase of fat mass, which has been described in the general population. 39 Multiple regression analysis confirmed that the age-related decrease of testosterone was attributable to the increase of BMI, rather than to the effect of aging per se.
38,40
The major pathogenetic factors suggested as being responsible for testosterone reduction in obesity are the decrease in the binding capacity of sex hormonebinding globulin (SHBG), the reduction of LH pulse amplitude, and higher aromatase activity. 41 Recent findings suggest a possible role of the adipocytesecreted hormone leptin, which increases with fat mass, 42 in this phenomenon. [43] [44] [45] [46] Although it is generally assumed that testosterone enhances libido and frequency of sexual acts (see in Tenover 13 for review), recent studies 16, 17 did not show any relationship between testosterone levels and ED prevalence and severity. In accordance with these latter studies, we did not find any correlation between testosterone levels and the severity of ED. However, patients reporting HSD showed significantly lower testosterone levels when compared with the rest of the sample, as previously reported. 27 These findings suggest that reduction of testosterone, although contributing to the reduction of sexual desire, could play a minor role in the pathogenesis of ED.
In conclusion, our findings suggest that the contribution of organic, relational, and intrapsychic factor to the pathogenesis of ED varies as a function of patients' age. The organic component is the most important determinant of ED in all age groups, but its contribution is more important in older patients. The relational component seems to be more relevant in older patient, while intrapsychic factors play a major role in younger ones. Among hormonal factors, the BMI-dependent reduction of testosterone in older patients does not seem to play a crucial role in the pathogenesis of ED. A better understanding of the relative contribution of age-related pathogenetic factors of ED could be of help in the design of appropriate therapeutic approaches.
